A pneumonia outbreak associated with a new coronavirus of probable bat origin
Вспышка пневмонии, связанная с новым коронавирусом вероятного летуче-прора-донора
2020-02-03
SCID: 54.1/2z8wsexs
Discuss with AI
2019-nCoVACE2 receptorSARS-related coronavirusesbat coronaviruswhole-genome sequence identity
Figures from the paper
Abstract (AI)
Abstract Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats 1–4 . Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans 5–7 . Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of . In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor—angiotensin converting enzyme II (ACE2)—as SARS-CoV.
Key Findings
1
2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus, indicating a probable bat origin.
2
2019-nCoV uses the same cellular entry receptor, angiotensin converting enzyme II (ACE2), as SARS-CoV.
3
A novel coronavirus (2019-nCoV) was identified and characterized as the cause of a human acute respiratory syndrome outbreak in Wuhan, China beginning 12 December 2019.
4
By 26 January 2020 there were 2,794 laboratory-confirmed infections and 80 deaths associated with the outbreak.
5
Full-length genomes from five early patients were nearly identical and share 79.6% sequence identity with SARS-CoV.
6
Pairwise protein sequence analysis of seven conserved non-structural protein domains places this virus within the SARS-related coronavirus species.
7
Virus isolated from a critically ill patient's bronchoalveolar lavage fluid could be neutralized by sera from several patients.
Research Object
The novel coronavirus 2019-nCoV (a SARS-related coronavirus closely related to bat coronaviruses)
Research Subject
Identification and characterization of the virus including genome sequencing, genetic relatedness to SARS-CoV and bat coronaviruses, protein/domain analysis, virus isolation and neutralization by patient sera, and usage of ACE2 as the cell entry receptor
Publication Details
Publication Date
2020-02-03
Journal
Publisher
ISSN
Cited by
21931
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by20
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status2020
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study2020
Therapeutic peptides: current applications and future directions2022
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China2020
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine2020
IL-6 in inflammation, autoimmunity and cancer2020
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV2020
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia2020
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-192020
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)2020
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐192020
Zoonotic origins of human coronaviruses2020
Zoonotic Diseases: Etiology, Impact, and Control2020
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series2020
Stroke in COVID-19: A systematic review and meta-analysis2020
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic2020
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE22020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-22020